Author: Peter Mansell

England’s National Institute for Health Research (NIHR) Clinical Research Network (CRN) has managed to reduce significantly the time it takes for studies funded by non-commercial organisations to be included in the NIHR research Portfolio.

Three leading cancer-research centres in the US have secured backing of US$120 million for Juno Therapeutics, a biotechnology start-up focused on novel immmunotherapies that could have a transformative impact in oncology.

The Alliance for Biomedical Research (Biomed Alliance) has welcomed the inclusion of a Strategic Scientific Panel for Health in the Horizon 2020 research and innovation programme recently voted through by the European Parliament.

US-based drug-development services company Aptuit has completed its senior management team by enlisting Dr Jonathan Goldman from ICON Clinical Research as chief executive officer (CEO).

The National Institute for Health Research Clinical Research Network (NIHR CRN) has struck a blow for the UK’s competitiveness as a base for international clinical trials by recruiting the first two global patients in a commercial study of an investigational cancer drug.